Achieve Life Sciences, Inc.
HealthcareNASDAQ:ACHV · NASDAQ Capital Market
+$0.00 today
Vol 1.17M · Avg 1.40M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+69.85%
Period High
$5.99
Period Low
$2.07
Latest
$5.52
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.18B
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$463.35M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$359.32M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$353.00M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$250.78M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$211.47M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$211.13M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$198.11M
Humacyte, Inc.
NASDAQ:HUMA
$177.24M
Immuneering Corporation
NASDAQ:IMRX
$152.11M
What is the latest ACHV filing?
The latest filing shown is DEF 14A dated Jun 8, 2026.
How many recent filings does ACHV have?
Intrinsic Alpha currently shows 20 recent filings for ACHV.
Explore More
Continue the stock analysis
Jump to another research area for this company.